Abhinav A. Shukla
CIK: 0001923377
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Shattuck Labs, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jul 6, 2026STTK
Shattuck Labs, Inc.
Exercise(M)Direct12.2K shares at avg. $3.57$43K - Jul 2, 2026STTK
Shattuck Labs, Inc.
Sale(S)Direct410 shares at avg. $7.01$3K - Jul 2, 2026STTK
Shattuck Labs, Inc.
Exercise(M)Direct410 shares at avg. $3.57$1K - Jul 1, 2026STTK
Shattuck Labs, Inc.
Exercise(M)Direct100 shares at avg. $3.57$357 - Jul 1, 2026STTK
Shattuck Labs, Inc.
Sale(S)Direct100 shares at avg. $7.07$707 - Jun 30, 2026STTK
Shattuck Labs, Inc.
Exercise(M)Direct23.4K shares at avg. $3.57$83K - Jun 30, 2026STTK
Shattuck Labs, Inc.
Sale(S)Direct23.4K shares at avg. $7.08$165K - May 21, 2026STTK
Shattuck Labs, Inc.
Exercise(M)DirectWarrants (Right to Buy)
5.1K shares- - May 21, 2026STTK
Shattuck Labs, Inc.
Award(A)Direct5.1K shares at avg. $1.08$6K - May 12, 2026STTK
Shattuck Labs, Inc.
Exercise(M)Direct2K shares at avg. $3.57$7K - May 12, 2026STTK
Shattuck Labs, Inc.
Sale(S)Direct2K shares at avg. $7.01$14K - Jan 10, 2026STTK
Shattuck Labs, Inc.
Award(A)DirectCommon Stock
315.5K shares- - Aug 25, 2025STTK
Shattuck Labs, Inc.
Award(A)Direct5.1K shares at avg. $0.87$4K - Jan 28, 2025STTK
Shattuck Labs, Inc.
Award(A)DirectCommon Stock
165.2K shares- - Jan 25, 2025STTK
Shattuck Labs, Inc.
Tax Payment(F)Direct2.3K shares at avg. $1.16$3K - Jan 10, 2025STTK
Shattuck Labs, Inc.
Tax Payment(F)Direct4.8K shares at avg. $1.19$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) | 12,153 | $3.57 | $43,386 | Direct |
| Jul 2, 2026 | STTK Shattuck Labs, Inc. | Sale(S) | 410 | $7.01 | $2,874 | Direct |
| Jul 2, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) | 410 | $3.57 | $1,464 | Direct |
| Jul 1, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) | 100 | $3.57 | $357 | Direct |
| Jul 1, 2026 | STTK Shattuck Labs, Inc. | Sale(S) | 100 | $7.07 | $707 | Direct |
| Jun 30, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) | 23,365 | $3.57 | $83,413 | Direct |
| Jun 30, 2026 | STTK Shattuck Labs, Inc. | Sale(S) | 23,365 | $7.08 | $165,424 | Direct |
| May 21, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) Warrants (Right to Buy) | 5,122 | - | - | Direct |
| May 21, 2026 | STTK Shattuck Labs, Inc. | Award(A) | 5,122 | $1.08 | $5,555 | Direct |
| May 12, 2026 | STTK Shattuck Labs, Inc. | Exercise(M) | 2,032 | $3.57 | $7,254 | Direct |
| May 12, 2026 | STTK Shattuck Labs, Inc. | Sale(S) | 2,032 | $7.01 | $14,244 | Direct |
| Jan 10, 2026 | STTK Shattuck Labs, Inc. | Award(A) Common Stock | 315,500 | - | - | Direct |
| Aug 25, 2025 | STTK Shattuck Labs, Inc. | Award(A) | 5,122 | $0.87 | $4,444 | Direct |
| Jan 28, 2025 | STTK Shattuck Labs, Inc. | Award(A) Common Stock | 165,200 | - | - | Direct |
| Jan 25, 2025 | STTK Shattuck Labs, Inc. | Tax Payment(F) | 2,261 | $1.16 | $2,623 | Direct |
| Jan 10, 2025 | STTK Shattuck Labs, Inc. | Tax Payment(F) | 4,830 | $1.19 | $5,748 | Direct |
1-16 of 16 transactions
About Shukla Abhinav A.
Shukla Abhinav A. (SEC CIK 0001923377) files insider reports with the SEC as Chief Technical Officer of Shattuck Labs, Inc. (STTK).
Signal8 holds 8 ownership filings by Shukla Abhinav A., all Form 4s, filed between Jan 13, 2025 and Jul 7, 2026. Those filings report 16 transactions, from Jan 10, 2025 to Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shukla Abhinav A.'s filings is in AUSTIN, TX.
Recent filings by Shukla Abhinav A.
- Jul 6, 2026: Option exercise of STTK shares (Form 4, code M).
- Jul 2, 2026: Open-market sale of STTK shares (Form 4, code S).
- Jul 2, 2026: Option exercise of STTK shares (Form 4, code M).
- Jul 1, 2026: Option exercise of STTK shares (Form 4, code M).
- Jul 1, 2026: Open-market sale of STTK shares (Form 4, code S).
Other insiders filing for Shattuck Labs, Inc. (STTK)
- Pandite Arundathy N., Chief Medical Officer
- Ashiya Mona, Director
- ORBIMED ADVISORS LLC, Director
- SIEGALL CLAY B, Director
- Baker Daniel G., Director
- Golumbeski George, Director